A treatment for anaemia associated with chronic kidney disease in dialysis patients has been approved in Japan.
List view / Grid view
First patients enrolled into European Phase III programme for potential first in class oral treatment for anaemia associated with chronic kidney disease
18 March 2014 | By Astellas
Roxadustat could change treatment of anaemia associated with CKD and remove the need for multiple injections...
AstraZeneca and FibroGen collaborate to develop and commercialise FG-4592, a treatment for anaemia in chronic kidney disease and end-stage renal disease
31 July 2013 | By AstraZeneca
Collaboration to include US, China and selected other markets...